Locations:
Searchimages: 1
video: 0
audio: 0
text: 0
Content is property of Cleveland Clinic and for news media use only.
CLEVELAND and DENMARK - In a new initiative that blends innovation in quantum technologies and artificial intelligence (AI) with clinical applications, the Novo Nordisk Foundation (NNF), together with Cleveland Clinic, has launched the Cleveland Clinic – Denmark: Quantum-AI Biomedical Frontiers Fellowship Program.
This program, crafted jointly by the Denmark-based NNF and Cleveland Clinic, is dedicated to integrating quantum technologies and AI into biomedical research and patient care, propelling the application of these technologies in medical science and healthcare.
"The collaboration between NNF and Cleveland Clinic is designed to enable the use of advanced critical technologies, such as quantum technology and AI, in biomedical research and practical clinical applications, ensuring these innovative technologies contribute to the understanding of disease and improving patient outcomes," said Lene Oddershede, Senior Vice President, Head of Natural and Technical at Novo Nordisk Foundation.
Program vision and strategic objectives
Denmark's strategic dedication to quantum technologies and AI, supported by substantial investments from the NNF and bolstered by the Danish government, has fostered a dynamic ecosystem for pioneering technological research.
Cleveland Clinic, a renowned academic medical center with a global footprint, is home to pioneering and flourishing biomedical research now supported by the world's only quantum computer fully dedicated to healthcare research as part of its Discovery Accelerator partnership with IBM. Cleveland Clinic’s expertise in medical research and clinical innovation, particularly its pioneering use of cutting-edge technologies for patient care, synergizes with Denmark’s technological strengths, enhancing the overall impact and reach of the fellowship program.
"This fellowship is a testament to the power of collaboration between Cleveland Clinic and the Novo Nordisk Foundation,” said Lara Jehi, MD, Chief Research Information Officer, Cleveland Clinic. “By combining our strengths, we aim to accelerate the translation of quantum technologies and artificial intelligence into clinical settings, fostering a new era of medical innovation that draws on the best of both our institutions. Our vision is to develop the biomedical researchers of tomorrow, those who can harness data and technology to benefit science and our patients."
Scientific focus and research opportunities
NNF will grant up to DKK 43 million ($6.2 million USD) over the next three years to support exchange of 12 researchers, providing them each with a three-year term to conduct high-level research either at Cleveland Clinic or in Denmark. In Cleveland, the fellows will also have the opportunity to work with IBM researchers collaborating with Cleveland Clinic scientists through the Discovery Accelerator partnership.
The program leverages quantum technologies and AI around key scientific areas, including:
Collaborative excellence and industrial engagement
In addition to a focus on academic research, this program also encourages applicants to consider industrial placements lasting three to six months with leading technology companies and startups. These placements are intended to provide practical experience and foster the translation of research innovations into market-ready medical solutions.
"We invite forward-thinking clinician scientists and post-doctoral researchers to apply for this unique opportunity," said Martin Ridderstråle, SVP and Head of Medical Science at NNF. “The application process will be rigorously managed by the NNF’s Committee on Interdisciplinary Research in collaboration with Cleveland Clinic, ensuring a thorough and meritocratic selection process.”
Early-stage researchers interested in becoming leaders at the vibrant intersection of quantum technologies or AI and medicine are encouraged to visit the NNF webpage for more details about the application process.
Cleveland Clinic is a nonprofit multispecialty academic medical center that integrates clinical and hospital care with research and education. Located in Cleveland, Ohio, it was founded in 1921 by four renowned physicians with a vision of providing outstanding patient care based upon the principles of cooperation, compassion and innovation. Cleveland Clinic has pioneered many medical breakthroughs, including coronary artery bypass surgery and the first face transplant in the United States. Cleveland Clinic is consistently recognized in the U.S. and throughout the world for its expertise and care. Among Cleveland Clinic’s 81,000 employees worldwide are more than 5,743 salaried physicians and researchers, and 20,160 registered nurses and advanced practice providers, representing 140 medical specialties and subspecialties. Cleveland Clinic is a 6,690-bed health system that includes a 173-acre main campus near downtown Cleveland, 23 hospitals, 276 outpatient facilities, including locations in northeast Ohio; Florida; Las Vegas, Nevada; Toronto, Canada; Abu Dhabi, UAE; and London, England. In 2023, there were 13.7 million outpatient encounters, 323,000 hospital admissions and observations, and 301,000 surgeries and procedures throughout Cleveland Clinic’s health system. Patients came for treatment from every state and 132 countries. Visit us at clevelandclinic.org. Follow us at twitter.com/CleClinicNews. News and resources available at newsroom.clevelandclinic.org.
Editor’s Note: Cleveland Clinic News Service is available to provide broadcast-quality interviews and B-roll upon request.
